Kindred Biosciences, Inc.
KINDelisted Aug 27, 2021- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001561743
Kindred Biosciences, Inc. was delisted on Aug 27, 2021; its insiders filed their last Form 4 on Sep 13, 2021; 87 institutions reported holding it in 13F filings for Q2 2021, worth $311.0M in total; no superinvestor held it.
Holders of 5% or more of KIN
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Kindred Biosciences, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Kindred Biosciences, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
18 Schedule 13D and 13G filings on Kindred Biosciences, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 14, 202211:13 AM ET | Ameriprise Financial Inc | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Point72 Asset Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Sep 13, 2021 | Park West Asset Management LLC | 13G/AOld format | – | – | – | SEC |
| Aug 31, 2021 | Gamco Investors, Inc. Et Al | 13D/AOld format | – | – | – | SEC |
| Aug 30, 20219:04 AM ET | Elanco Animal Health Inc | 13D/AOld format | – | – | – | SEC |
| Aug 5, 2021 | Gamco Investors, Inc. Et Al | 13D/AOld format | – | – | – | SEC |
| Aug 3, 2021 | Gamco Investors, Inc. Et Al | 13DOld format | – | New | – | SEC |
| Jul 12, 20218:29 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jun 30, 2021 | Magnetar Financial LLC | 13D/AOld format | – | – | – | SEC |
| Jun 25, 20214:30 PM ET | Elanco Animal Health Inc | 13DOld format | – | New | – | SEC |
| Jun 25, 2021 | Magnetar Financial LLC | 13DOld format | – | New | – | SEC |
| Jun 24, 2021 | Integrated Core Strategies (US) LLC | 13GOld format | – | New | – | SEC |
| Apr 1, 2021 | Point72 Asset Management, L.P. | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | Park West Asset Management LLC | 13G/AOld format | – | – | – | SEC |
| Feb 12, 202110:04 AM ET | Ameriprise Financial Inc | 13GOld format | – | New | – | SEC |
| Feb 12, 2021 | Chin Richard | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Vanguard Group Inc | 13GOld format | – | New | – | SEC |
| Jan 29, 20215:23 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Kindred Biosciences, Inc. shares.
No Form 144 notices for Kindred Biosciences, Inc. are on file.